Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Hamden biotech Vanessa advances in Turkey

Vanessa Research has been granted regulatory approval by the Turkish Ministry of Health to conduct a Phase II Clinical Trial for Shylicine®, an investigational oral...

| By Bill Kelly

SpringWorks gets fast track re neurofibromatosis

SpringWorks Therapeutics reports that the FDA has granted Fast Track designation for PD-0325901, an investigational, oral, small molecule inhibitor of MEK1 and MEK2, for the treatment...

| By Bill Kelly

Connecticut companies exhibit at BIO convention

Four New Haven-area companies exhibiting at Bio 2019, one the world’s largest forums for the biotech sector. More than 16,000 attendees are taking part in...

| By Bill Kelly

Intensity presents positive Phase 1/2 results

Intensity Therapeutics reports positive preliminary results from the company’s ongoing Phase 1/2 clinical trial of its lead product candidate, INT230-6, in a poster at the American...

| By Kelley Gipson

Bayer and Arvinas to collaborate

Bayer and Arvinas report an agreement to leverage Arvinas’ novel PROTAC® protein degrader technology to develop new human therapeutics for patients with cardiovascular, oncological, and...

| By Bill Kelly

Sema4 debuts genetic testing services

Stamford-headquartered Sema4 has introduced a line of genomic testing services and digital tools designed to aid oncologists treating cancer patients from the risk assessment to...

| By Kelley Gipson

Thetis reports data supporting it IBD candidate

Thetis Pharmaceuticals reports preclinical data supporting the potential of its lead candidate, TP-317, in inflammatory bowel disease (IBD). TP-317 is a novel salt of Resolvin...

| By Kelley Gipson

Cybrexa data support its alphalex™ technology

Cybrexa Therapeutics reports preclinical data supporting the potential of its proprietary alphalex™ technology platform. Results from multiple preclinical studies demonstrate that alphalex™ successfully enables the combination...

| By Bill Kelly

BioCT welcomes new member Strategic Spaces

Strategic Spaces is a leader in prefabricated construction for interior spaces and commercial furniture solutions. With a trained team of interior designers and construction project...